There is also evidence of necroptotic pathway activation and increased RIPK1 and RIPK3 expression in pathologies of myocardial infarction progression in response to myocardial ischemia (MI) and hypoxia, due to which impaired cardiac functions and the increased incidences of cardiovascular mortality result. Here, RIPK1 is linked to myocardial infarction.